0001145549-23-046682.txt : 20230814 0001145549-23-046682.hdr.sgml : 20230814 20230814093405 ACCESSION NUMBER: 0001145549-23-046682 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20230531 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRUST FOR PROFESSIONAL MANAGERS CENTRAL INDEX KEY: 0001141819 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-10401 FILM NUMBER: 231166851 BUSINESS ADDRESS: STREET 1: U.S. BANCORP FUND SERVICES LLC STREET 2: 615 EAST MICHIGAN ST 2ND FLOOR CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 4147655067 MAIL ADDRESS: STREET 1: U.S. BANCORP FUND SERVICES LLC STREET 2: 615 EAST MICHIGAN ST 2ND FLOOR CITY: MILWAUKEE STATE: WI ZIP: 53202 FORMER COMPANY: FORMER CONFORMED NAME: ZODIAC TRUST DATE OF NAME CHANGE: 20010601 0001141819 S000028010 Barrett Growth Fund C000085208 Barrett Growth Fund BGRWX 0001141819 S000028264 Jensen Quality Value Fund C000086400 Jensen Quality Value Fund - I Shares JNVIX C000086401 Jensen Quality Value Fund - J Shares JNVSX C000216771 Jensen Quality Value Fund - Y Shares JNVYX 0001141819 S000067414 Jensen Global Quality Growth Fund C000216768 Jensen Global Quality Growth Fund - Y Shares JGQYX C000216769 Jensen Global Quality Growth Fund - J Shares JGQSX C000216770 Jensen Global Quality Growth Fund - I Shares JGQIX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001141819 XXXXXXXX false false false N-1A S000028010 true S000028264 true S000067414 true Trust for Professional Managers 811-10401 0001141819 549300O1N816L3GGRD45 615 East Michigan Street Milwaukee 53202 US-WI US 5136298104 U.S. Bank, N.A. 1555 North River Center Drive Suite 302 Milwaukee 53212 8336121912 Custody Data Convergence Investment Partners, LLC 3801 PGA Boulevard Suite 1001 Palm Beach Gardens 33410 8776779414 Advisory data Rockefeller & Co. LLC 45 Rockefeller Plaza 5th Floor New York 10111 8553696209 Advisory data Bright Rock Capital Management LLC 2036 Washington Street Hanover 02339 8662737223 Advisory data Dearborn Partners, L.L.C. 200 West Madison Street Suite 1950 Chicago 60606 8889833380 Advisory data Jensen Investment Management, Inc. 5500 Meadows Road Suite 200 Lake Oswego 97035 8009924144 Advisory data U.S. Bancorp Fund Services, LLC 615 East Michigan Street Milwaukee 53202 8336121912 Transfer agency, fund accounting and fund administration data Barrett Asset Management, LLC 90 Park Avenue 34th Floor New York 10016 8773636333 Advisory data Quasar Distributors, LLC 111 East Kilborn Avenue Suite 2200 Milwaukee 53202 8336121912 Distribution data Foreside Fund Services, LLC 3 Canal Plaza Suite 100 Portland 04101 8662516920 Distribution data PT Asset Management, LLC 500 W Madison Suite 470 Chicago 60661 8882823220 Advisory data Envestnet Asset Management, Inc. One North Wacker Drive Suite 1925 Chicago 60606 8667627338 Advisory data CrossingBridge Advisors, LLC 427 Bedford Road Suite 230 Pleasantville 10570 8888982780 Advisory data Terra Firma Asset Management LLC 1160 Battery Street Suite 100 East Building San Francisco 94111 8003116583 Advisory data Mairs & Power, Inc. 30 East 7th Street Suite 2500 Saint Paul 55101 8558392800 Advisory data N N N N-1A 27 Y John P. Buckel N/A Y Gregory M. Wesley N/A N Lisa Zuniga Ramirez N/A N Erik K. Olstein N/A N Vincent P. Lyles N/A N Michael D. Akers N/A N Gary A. Drska N/A N Deanna B Marotz N/A 615 E. Michigan St. Milwaukee 53202 XXXXXX N N N N N N Quasar Distributors, LLC 8-52323 000103848 N/A N Foreside Funds Distributors, LLC 8-32480 000031334 N/A N N Deloitte & Touche LLP 00034 N/A Cohen & Company, Ltd. 00925 N/A N N N N N N N Barrett Growth Fund S000028010 254900NQR7L1E64ZLU55 N 1 0 0 N/A N N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N Barrett Asset Management, LLC 801-72395 000157047 7VC3GCA7MO0VRVSM1Z08 N U.S. Bancorp Fund Services, LLC 85-11357 N/A N N N CBOE Global Markets, Inc. 529900RLNSGA90UPEH54 N Refinitiv US LLC 213800HQORQAP68CJJ04 N Bank Of America Merrill Lynch N/A N Standard and Poors Financial Services LLC 549300U4VWNITEKO2881 N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N Bloomberg L.P. 549300B56MD0ZC402L06 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC 85-11357 N N N WILLIAM BLAIR & COMPANY L.L.C. 8-2698 000001252 549300J0P7XYE8BMZ775 1555.000000000000 NATIONAL FINANCIAL SERVICES LLC 8-26740 000013041 549300JRHF1MHHWUAW04 60.000000000000 1615.000000000000 0.000000000000 Y 23634593.000000000000 N N N N Jensen Quality Value Fund S000028264 254900FVV5POADR97235 N 3 0 0 N/A N N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N Jensen Investment Management, Inc. 801-32726 000105281 549300VD47D3K1WAVR22 N U.S. Bancorp Fund Services, LLC 85-11357 N/A N N N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Bloomberg L.P. 549300B56MD0ZC402L06 N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N Bank Of America Merrill Lynch N/A N Standard and Poors Financial Services LLC 549300U4VWNITEKO2881 N Refinitiv US LLC 213800HQORQAP68CJJ04 N CBOE Global Markets, Inc. 529900RLNSGA90UPEH54 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC 85-11357 N N N INSTINET, LLC 8-52614 000104162 5493000KYO0CHOUH1K62 3222.000000000000 FIS BROKERAGE & SECURITIES SERVICES LLC 8-23669 000007897 549300MGMN3RKMU8FT57 740.000000000000 COWEN EXECUTION SERVICES LLC 8-46838 000035693 5493005RJDJD18OPUP27 499.000000000000 PAVILION GLOBAL MARKETS LTD. 8-52850 000104387 89RLTMP2WM4KXYJMWI06 CA 297.000000000000 4758.000000000000 0.000000000000 Y 186465611.000000000000 Uncommitted 10000000.000000000000 N N N Jensen Global Quality Growth Fund S000067414 549300F7FOMXOGFU5B38 N 3 0 0 N/A Y N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N Jensen Investment Management, Inc. 801-32726 000105281 549300VD47D3K1WAVR22 N U.S. Bancorp Fund Services, LLC 85-11357 N/A N N N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Bloomberg L.P. 549300B56MD0ZC402L06 N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N Standard and Poors Financial Services LLC 549300U4VWNITEKO2881 N Bank Of America Merrill Lynch N/A N Refinitiv US LLC 213800HQORQAP68CJJ04 N CBOE Global Markets, Inc. 529900RLNSGA90UPEH54 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC 85-11357 N N N INSTINET, LLC 8-23669 000007897 549300MGMN3RKMU8FT57 3330.000000000000 3330.000000000000 INSTINET, LLC 8-23669 000007897 549300MGMN3RKMU8FT57 11318.000000000000 11318.000000000000 Y 41098322.000000000000 Uncommitted 2000000.000000000000 N N N true INTERNAL CONTROL RPT 2 ncen-barrett.htm BARRETT

  

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

To the Shareholders of Barrett Growth Fund and 

Board of Trustees of Trust for Professional Managers 

  

In planning and performing our audit of the financial statements of Barrett Growth Fund (the “Fund”), a series of Trust for Professional Managers, as of and for the year ended May 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting.  Accordingly, we express no such opinion. 

  

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.  

  

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of May 31, 2023.  

  

This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ COHEN & COMPANY, LTD. 

  

COHEN & COMPANY, LTD. 

Milwaukee, Wisconsin 

July 27, 2023 

  

INTERNAL CONTROL RPT 3 ncen-jensen.htm JENSEN

  

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

To the Shareholders of Jensen Quality Value Fund and Jensen Global Quality Growth Fund and 

Board of Trustees of Trust for Professional Managers  

  

In planning and performing our audit of the financial statements of Jensen Quality Value Fund and Jensen Global Quality Growth Fund (the “Funds”), each a series of Trust for Professional Managers, as of and for the year ended May 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds’ internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting.  Accordingly, we express no such opinion. 

  

The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.  

  

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds’ annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Funds’ internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Funds’ internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of May 31, 2023.  

  

This report is intended solely for the information and use of management and the Board of Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ COHEN & COMPANY, LTD. 

  

COHEN & COMPANY, LTD. 

Milwaukee, Wisconsin 

July 27, 2023